Wanted to start another thread after my question on the impairment charge yesterday. Other thread got out of hand:
This is where are are at:
1. Oral presentation at ASH on SGI-110. Free, you think this is a good thing.
2. No real clear explaination what the $7.4M impairment charge in Q3 is. Is it AT7519 or MP470 or GSK shutdown from earlier this year? I have asked Tim. No response.
3. Update on AT7519. I have asked Tim. No response.
4. Man@#$@ and others will be presenting tomorrow.
Did you notice the current share price of SRPT?Supergen/Astex holds for years and then sells. Recent price is 27.50+. Can you ask what there reason was for holding so long and then selling? Why did they buy or get shares in the first place?
Mero about srpt my words exactly.The reason for buying avii was for there investment in a drug they believe in. To dump the shares for a huge lost and make a small amount of chump change only lack of faith in what they first believe in.